Ballaron Craig 4
4 · Verrica Pharmaceuticals Inc. · Filed Aug 26, 2020
Insider Transaction Report
Form 4
Ballaron Craig
Director
Transactions
- Purchase
Common Stock
2020-08-24$9.16/sh+5,228$47,888→ 5,228 total - Purchase
Common Stock
2020-08-25$8.57/sh+4,772$40,896→ 10,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.03 to $9.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2).
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.45 to $8.81 inclusive.